Cipher Pharmaceuticals (CPH) News Today C$14.61 -0.11 (-0.75%) (As of 11:31 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Stifel Nicolaus Has Lowered Expectations for Cipher Pharmaceuticals (TSE:CPH) Stock PriceNovember 15, 2024 | americanbankingnews.comTSE:CPH FY2025 EPS Forecast Reduced by Leede FinancialNovember 12, 2024 | americanbankingnews.comLeede Financial Analysts Cut Earnings Estimates for TSE:CPHCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Stock analysts at Leede Financial dropped their FY2025 earnings estimates for shares of Cipher Pharmaceuticals in a note issued to investors on Friday, November 8th. Leede Financial analyst D. Loe now anticipates that the companyNovember 11, 2024 | marketbeat.comCipher Pharmaceuticals Third Quarter 2024 Earnings: EPS Misses ExpectationsNovember 11, 2024 | uk.finance.yahoo.comCipher Pharmaceuticals Reports Third Quarter 2024 ResultsNovember 8, 2024 | theglobeandmail.comCipher Pharmaceuticals’ Revenue Soars After Natroba AcquisitionNovember 7, 2024 | markets.businessinsider.comWhat To Expect From Cipher Pharmaceuticals Inc (TSX:CPH) Q3 2024 EarningsNovember 7, 2024 | finance.yahoo.comEarnings To Watch: Cipher Pharmaceuticals Inc (TSX:CPH) Reports Q3 2024 ResultNovember 6, 2024 | finance.yahoo.comCipher Pharmaceuticals Schedules Q3 2024 Earnings Release and Conference CallNovember 4, 2024 | finance.yahoo.comStifel Canada Issues Negative Estimate for TSE:CPH EarningsCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Research analysts at Stifel Canada lowered their Q3 2024 earnings estimates for Cipher Pharmaceuticals in a report released on Tuesday, October 22nd. Stifel Canada analyst J. Keywood now forecasts that the company will earn $0.03October 25, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) PT Raised to C$19.00 at Stifel NicolausStifel Nicolaus lifted their target price on Cipher Pharmaceuticals from C$17.00 to C$19.00 in a research note on Thursday.October 24, 2024 | marketbeat.comEquities Analysts Offer Predictions for TSE:CPH Q4 EarningsCipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Equities research analysts at Stifel Canada raised their Q4 2024 earnings per share estimates for Cipher Pharmaceuticals in a report issued on Tuesday, October 22nd. Stifel Canada analyst J. Keywood now expects that the company wOctober 24, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Crosses Above 50 Day Moving Average - Here's WhyCipher Pharmaceuticals (TSE:CPH) Stock Price Passes Above 50 Day Moving Average - Should You Sell?October 4, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Below Fifty Day Moving Average of $14.21Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50 Day Moving Average of $14.21September 25, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Rating Lowered by Leede FinancialLeede Financial downgraded shares of Cipher Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research note on Friday.September 17, 2024 | marketbeat.comCanadian Investment Regulatory Organization Trading Halt - CPHSeptember 14, 2024 | ca.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Shares Down 18.3% Cipher Pharmaceuticals (TSE:CPH) Stock Price Down 18.3%September 13, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $19.69Cipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $19.69August 29, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $16.60Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $16.60August 22, 2024 | marketbeat.comCipher Pharmaceuticals Inc (PHE.SG)August 17, 2024 | nz.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High at $14.63Cipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $14.63August 16, 2024 | marketbeat.comCipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You ThinkAugust 15, 2024 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Rating Increased to Strong-Buy at Stifel CanadaStifel Canada raised shares of Cipher Pharmaceuticals from a "hold" rating to a "strong-buy" rating in a research note on Monday.August 14, 2024 | marketbeat.comStifel Canada Comments on Cipher Pharmaceuticals Inc.'s Q3 2024 Earnings (TSE:CPH)Cipher Pharmaceuticals Inc. (TSE:CPH - Free Report) (NASDAQ:CPHR) - Analysts at Stifel Canada boosted their Q3 2024 earnings estimates for Cipher Pharmaceuticals in a research report issued to clients and investors on Monday, August 12th. Stifel Canada analyst J. Keywood now expects that the compAugust 14, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Lifted to "Buy" at Stifel NicolausStifel Nicolaus raised Cipher Pharmaceuticals from a "hold" rating to a "buy" rating and raised their target price for the company from C$9.50 to C$16.00 in a report on Tuesday.August 13, 2024 | marketbeat.comCipher Pharmaceuticals Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 12, 2024 | finance.yahoo.comCipher Pharmaceuticals earnings preview: what Wall Street is expectingAugust 9, 2024 | markets.businessinsider.comCipher Pharmaceuticals Reports Second Quarter 2024 ResultsAugust 9, 2024 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High at $13.25Cipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $13.25August 6, 2024 | marketbeat.comScant Lineup of Stocks at 52-Week HighsAugust 6, 2024 | baystreet.caCipher Pharmaceuticals (CPH) Set to Announce Quarterly Earnings on ThursdayCipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) will be releasing earnings after the market closes on Thursday, August 8, Zacks reports.August 2, 2024 | marketbeat.comCipher Pharmaceuticals Schedules Q2 2024 Earnings Release and Conference CallAugust 1, 2024 | finance.yahoo.comCipher Pharmaceuticals Inc.'s (TSE:CPH) 31% gain last week benefited both individual investors who own 53% as well as insidersJuly 31, 2024 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $11.74Cipher Pharmaceuticals (TSE:CPH) Reaches New 1-Year High at $11.74July 30, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Trading Up 24.9%Cipher Pharmaceuticals (TSE:CPH) Stock Price Up 24.9%July 29, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50-Day Moving Average of $8.65Cipher Pharmaceuticals (TSE:CPH) Shares Pass Below 50 Day Moving Average of $8.65July 13, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50-Day Moving Average of $8.72Cipher Pharmaceuticals (TSE:CPH) Shares Cross Below 50 Day Moving Average of $8.72June 27, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Stock Crosses Above 50-Day Moving Average of $8.80Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50-Day Moving Average of $8.80May 30, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50 Day Moving Average of $8.70Cipher Pharmaceuticals (TSE:CPH) Stock Price Passes Above Fifty Day Moving Average of $8.70May 22, 2024 | marketbeat.comCipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50May 13, 2024 | finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Cut to Hold at Stifel NicolausStifel Nicolaus lowered shares of Cipher Pharmaceuticals from a "buy" rating to a "hold" rating and raised their price objective for the company from C$8.00 to C$9.50 in a research report on Monday.May 13, 2024 | marketbeat.comCipher Pharmaceuticals (TSE:CPH) Hits New 1-Year High at $10.33Cipher Pharmaceuticals (TSE:CPH) Reaches New 52-Week High at $10.33May 10, 2024 | marketbeat.comCipher Pharmaceuticals (CPH) Scheduled to Post Quarterly Earnings on ThursdayCipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) will be releasing earnings after the market closes on Thursday, May 9, Zacks reports.May 6, 2024 | marketbeat.comCipher Pharmaceuticals: Stocks Overvalued by Analyst Consensus on TSX (CPH)April 28, 2024 | theglobeandmail.comClosing Bell: Cipher Pharmaceuticals Inc flat on Friday (CPH)April 27, 2024 | theglobeandmail.comStocks in play: Cipher PharmaceuticalsApril 3, 2024 | ca.finance.yahoo.comCipher Pharmaceuticals (TSE:CPH) Shares Down 7.9% Cipher Pharmaceuticals (TSE:CPH) Stock Price Down 7.9%April 1, 2024 | marketbeat.comCipher Pharmaceuticals: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CPH)March 28, 2024 | theglobeandmail.comCipher Pharmaceuticals (TSE:CPH) Hits New 12-Month High at $9.17Cipher Pharmaceuticals (TSE:CPH) Sets New 12-Month High at $9.17March 21, 2024 | marketbeat.comEarnings call: Cipher Pharmaceuticals outlines growth and financialsMarch 17, 2024 | investing.com Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. CPH Media Mentions By Week CPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPH News Sentiment▼-0.670.47▲Average Medical News Sentiment CPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPH Articles This Week▼11▲CPH Articles Average Week Get Cipher Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRON News GUD News WEED News ACB News OGI News CRDL News RX News HLS News MDP News CWEB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:CPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cipher Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cipher Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPH Stock Alerts